Pregabalin add-on for drug-resistant focal epilepsy
This evidence summary presents the best available evidence regarding pregabalin add-on for drug-resistant focal epilepsy.1
Introduction
Approximately 3–3.5% of Australians will experience epilepsy at some point...
From the president: Medicine safety is vital to improving disability care
Last month, I had the pleasure of meeting many of you at our annual PSA22 flagship conference in Sydney, where we also launched our...
Anxiety is often untreated – how pharmacists can help
A new MedicineWise program aims to increase the number of patients seeking help for anxiety and other mood disorders by educating healthcare professionals.
Anxiety disorders,...
Blockchain exec pushing for the end of paper prescriptions
Australian laws requiring use of paper documents prevent new technological solutions that could inhibit prescription fraud.
That’s the diagnosis of Dr Tal Rapke, chief executive...
Pharmacists’ true value not yet realised: PSA
Pharmacists are the healthcare professionals best placed to address the crisis in medicine safety in Australia, and could contribute to cost savings of $1.4...
Opioids, antidepressants and the risk of hip fracture
A recent study identified that the risk of hip fracture was increased with the use of psychotropic drugs in elderly people. The highest risk...
